Cardiac biomarkers in chronic renal disease

Scandinavian Journal of Clinical and Laboratory Investigation

Volumn 68, Issue SUPPL. 241, 2008, Pages 104-108

  Collinson, Paul O ^a,b   Gaze, David C ^a  

^a ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^b ST GEORGE S HOSPITAL   (United Kingdom)

Author keywords

Acute coronary syndrome; B type natriuretic peptide; Biomarkers; Cardiac troponin I; Cardiac troponin T; End stage renal disease; Myocardial infarction; N terminal B type natriuretic peptide; Natriuretic peptides; Prognostic risk assessment; Renal dysfunction

Indexed keywords

BIOLOGICAL MARKER; BRAIN NATRIURETIC PEPTIDE; CARDIAC BIOMARKER; CREATINE KINASE; CREATINE KINASE MB; TROPONIN; ATRIAL NATRIURETIC FACTOR; PEPTIDE FRAGMENT; PRO BRAIN NATRIURETIC PEPTIDE (1 76); PRO-BRAIN NATRIURETIC PEPTIDE (1-76); TROPONIN I; TROPONIN T;

CHRONIC KIDNEY DISEASE; CONFERENCE PAPER; ENZYME ACTIVITY; HEART DEATH; HEART MUSCLE CELL; HEART VENTRICLE FUNCTION; HUMAN; KIDNEY FAILURE; PRIORITY JOURNAL; PROTEIN SECRETION; ARTICLE; BLOOD; CHRONIC KIDNEY FAILURE; NECROSIS; PATHOLOGY;

ATRIAL NATRIURETIC FACTOR; BIOLOGICAL MARKERS; HUMANS; KIDNEY FAILURE, CHRONIC; MYOCYTES, CARDIAC; NATRIURETIC PEPTIDE, BRAIN; NECROSIS; PEPTIDE FRAGMENTS; TROPONIN I; TROPONIN T;

EID: 45849122050     PISSN: 00365513     EISSN: 15027686     Source Type: Journal    
DOI: 10.1080/00365510802150265     Document Type: Conference Paper

References (30)

1. Schiffrin EL, Lipman ML, Mann JF. Chronic kidney disease: effects on the cardiovascular system. Circulation 2007;85-97.
2. Wison S, Foo K, Cunningham J, Cooper J, Deaner A, Knight C, et al. Renal function and risk stratification in acute coronary syndromes. Am J Cardiol 2003;1051-4.
3. Wu AH, Laios I, Green S, Gornet TG, Wong SS, Parmley L, et al. Immunoassays for serum and urine myoglobin: myoglobin clearance assessed as a risk factor for acute renal failure. Clin Chem 1994;796-802.
4. Katus HA, Looser S, Hallermayer K, Remppis A, Scheffold T, Borgya A, et al. Development and in vitro characterization of a new immunoassay of cardiac troponin T. Clin Chem 1992; 386-93.
5. Collinson PO, Chandler HA, Stubbs PJ, Moseley DS, Lewis D, Simmons MD. Measurement of serum troponin T, creatine kinase MB isoenzyme, and total creatine kinase following arduous physical training. Ann Clin Biochem 1995;450-3.
6. Adams JE III, Bodor GS, Davila-Roman VG, Delmez JA, Apple FS, Ladenson JH, et al. Cardiac troponin I. A marker with high specificity for cardiac injury [see comments]. Circulation 1993;101-6.
7. Bhayana V, Gougoulias T, Cohoe S, Henderson AR. Discordance between results for serum troponin T and troponin I in renal disease [see comments]. Clin Chem 1995;312-17.
8. Collinson PO, Stubbs PJ, Rosalki SB. Cardiac troponin T in renal disease. Clin Chem 1995;1671-3.
9. Muller-Bardorff M, Hallermayer K, Schroder A, Ebert C, Borgya A, Gerhardt W, et al. Improved troponin T ELISA specific for cardiac troponin T isoform: assay development and analytical and clinical validation [see comments]. Clin Chem 1997;458-66.
10. Collinson PO, Hadcocks L, Foo Y, Rosalki SB, Stubbs PJ, Morgan SH, et al. Cardiac troponins in patients with renal dysfunction. Ann Clin Biochem 1998;380-6.
11. Hickman PE, Koerbin G, Southcott E, Tate J, Dimeski G, Carter A, et al. Newer cardiac troponin I assays have similar performance to troponin T in patients with end-stage renal disease. Ann Clin Biochem 2007;285-9.
12. Bodor GS, Survant L, Voss EM, Smith S, Porterfield D, Apple FS. Cardiac troponin T composition in normal and regenerating human skeletal muscle [see comments]. Clin Chem 1997;476-84.
13. Haller C, Zehelein J, Remppis A, Muller-Bardorff M, Katus HA. Cardiac troponin T in patients with end-stage renal disease: absence of expression in truncal skeletal muscle [published erratum appears in Clin Chem 1998 Jul;44(7):1586] [see comments]. Clin Chem 1998;930-8.
14. Fredericks S, Bainbridge K, Murray JF, Collinson PO, Carter ND, Holt DW. Measurement of cardiac troponin I in striated muscle using three experimental methods. Ann Clin Biochem 2003;244-8.
15. Fredericks S, Degens H, McKoy G, Bainbridge K, Collinson PO, Coulton G, et al. Effect of denervation on the content of cardiac troponin-T and cardiac troponin-I in rat skeletal muscle. Clin Biochem 2007;423-6.
16. Khan NA, Hemmelgarn BR, Tonelli M, Thompson CR, Levin A. Prognostic value of troponin T and I among asymptomatic patients with end-stage renal disease: a meta-analysis. Circulation 2005;3088-96.
17. Aviles RJ, Askari AT, Lindahl B, Wallentin L, Jia G, Ohman EM, et al. Troponin T levels in patients with acute coronary syndromes, with or without renal dysfunction. N Engl J Med 2002;2047-52.
18. Thygesen K, Alpert JS, White HD. Universal definition of myocardial infarction. J Am Coll Cardiol 2007;2173-95.
19. Diris JH, Hackeng CM, Kooman JP, Pinto YM, Hermens WT, Dieijen-Visser MP. Impaired renal clearance explains elevated troponin T fragments in hemodialysis patients. Circulation 2004;23-5.
20. Fahie-Wilson MN, Carmichael DJ, Delaney MP, Stevens PE, Hall EM, Lamb EJ. Cardiac troponin T circulates in the free, intact form in patients with kidney failure. Clin Chem 2006;414-20.
21. Sharma R, Gaze DC, Pellerin D, Mehta RL, Gregson H, Streather CP, et al. Cardiac structural and functional abnormalities in end stage renal disease patients with elevated cardiac troponin T. Heart 2006;804-9.
22. Sharma R, Pellerin D, Gaze DC, Shah JS, Streather CP, Collinson PO, et al. Dobutamine stress echocardiography and cardiac troponin T for the detection of significant coronary artery disease and predicting outcome in renal transplant candidates. Eur J Echocardiogr 2005;327-35.
23. deFilippi CR, Thorn EM, Aggarwal M, Joy A, Christenson RH, Duh SH, et al. Frequency and cause of cardiac troponin T elevation in chronic hemodialysis patients from study of cardiovascular magnetic resonance. Am J Cardiol 2007;885-9.
24. Goetze JP, Jensen G, Moller S, Bendtsen F, Rehfeld JF, Henriksen JH. BNP and N-terminal proBNP are both extracted in the normal kidney. Eur J Clin Invest 2008;8-15.
25. DeFilippi C, van Kimmenade RR, Pinto YM. Amino-terminal pro-B-type natriuretic peptide testing in renal disease. Am J Cardiol 2008;82-8.
26. Zoccali C, Mallamaci F, Benedetto FA, Tripepi G, Parlongo S, Cataliotti A, et al. Cardiac natriuretic peptides are related to left ventricular mass and function and predict mortality in dialysis patients. J Am Soc Nephrol 2001;1508-15.
27. Sharma R, Gaze DC, Pellerin D, Mehta RL, Gregson H, Streather CP, et al. Raised plasma N-terminal pro-B-type natriuretic peptide concentrations predict mortality and cardiac disease in end-stage renal disease. Heart 2006;1518-19.
28. Hawkridge AM, Heublein DM, Bergen HR III, Cataliotti A, Burnett JC Jr, Muddiman DC. Quantitative mass spectral evidence for the absence of circulating brain natriuretic peptide (BNP-32) in severe human heart failure. Proc Natl Acad Sci USA 2005;17442-7.
29. Giuliani I, Rieunier F, Larue C, Delagneau JF, Granier C, Pau B, et al. Assay for measurement of intact B-type natriuretic peptide prohormone in blood. Clin Chem 2006;1054-61.
30. Seferian KR, Tamm NN, Semenov AG, Mukharyamova KS, Tolstaya AA, Koshkina EV, et al. The brain natriuretic peptide (BNP) precursor is the major immunoreactive form of BNP in patients with heart failure. Clin Chem 2007;866-73.